Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South Africa
Clinical trial NCT04143061 · COMPLETED
Trial details
- NCT number
- NCT04143061
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-30
- Primary completion
- 2023-01-28
- Enrollment
- 1328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.